| Q36107948 | 'Waiting at the dinner table for scraps': a qualitative study of the help-seeking experiences of heterosexual men living with HIV infection |
| Q42218121 | 2014 European Guideline on HIV testing |
| Q39144018 | A critical insight into the development pipeline of microfluidic immunoassay devices for the sensitive quantitation of protein biomarkers at the point of care. |
| Q38382560 | A novel strategy to reduce very late HIV diagnosis in high-prevalence areas in South-West England: serious incident audit |
| Q28543212 | A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals |
| Q37972113 | Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy |
| Q59811972 | Ageing in patients with chronic HIV infection: impact of hypercoagulation |
| Q35393050 | Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles |
| Q39641497 | An analysis of patients' understanding of 'routine' preoperative blood tests and HIV screening. Is no news really good news? |
| Q45145750 | An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database). |
| Q40841775 | An observational study of comorbidity and healthcare utilisation among HIV-positive patients aged 50 years and over |
| Q39061949 | Antiretroviral therapy options for treatment-naive patients with HIV-1. |
| Q58564811 | Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016 |
| Q37089267 | Assessing the HIV rapid test in the fight against the HIV/AIDS epidemic in Trinidad |
| Q36870581 | Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN database |
| Q28606934 | Association of Cardiometabolic Multimorbidity With Mortality |
| Q42246080 | CD4 counts and mortality in virologically suppressed US veterans |
| Q36783221 | Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights |
| Q40152550 | Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985-2010. |
| Q34541959 | Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy |
| Q50149700 | Cocaine use may induce telomere shortening in individuals with HIV infection |
| Q92324483 | Cohort profile: Development and profile of a population-based, retrospective cohort of diagnosed people living with HIV in Ontario, Canada (Ontario HIV Laboratory Cohort) |
| Q35794099 | Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study |
| Q96959223 | Conceptualising, measuring, and addressing HIV-related stigma: towards reducing disparities in HIV testing and HIV-related outcomes among migrants of HIV unknown or negative status in high-income countries |
| Q39929987 | Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial |
| Q40215329 | Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical tri |
| Q28610686 | Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada |
| Q40759306 | Design and structure of the Estonian HIV Cohort Study (E-HIV). |
| Q43789646 | Determinants of adherence in a cohort of Belgian HIV patients: a pilot study |
| Q33626194 | Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment |
| Q28545222 | Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study |
| Q37156843 | Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors |
| Q34455423 | Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? |
| Q28550445 | Early HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM Populations |
| Q51196202 | Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance. |
| Q40810270 | Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection. |
| Q36715732 | Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomes |
| Q44757517 | Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection |
| Q52604630 | Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV. |
| Q41471847 | Estimating trends in life expectancy in HIV-positive individuals |
| Q37696500 | Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions |
| Q60044846 | Evaluation of an educational intervention to increase HIV-testing in high HIV prevalence general practices: a pilot feasibility stepped-wedged randomised controlled trial |
| Q36484214 | Expanded HIV Testing and Linkage to Care: Conventional vs. Point-of-Care Testing and Assignment of Patient Notification and Linkage to Care to an HIV Care Program |
| Q36777532 | Feasibility and success of HIV point-of-care testing in an emergency department in an urban Canadian setting |
| Q38421157 | Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group - results from the ANRS-VESPA2 Study, France |
| Q41860717 | Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes |
| Q37135280 | Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail |
| Q37482051 | Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India |
| Q53795511 | Gestational trophoblastic neoplasm and women living with HIV and/or AIDS. |
| Q28534017 | HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China |
| Q45182584 | HIV disclosure in the workplace |
| Q41450742 | HIV in young people: characteristics and predictors for late diagnosis of HIV. |
| Q44471036 | HIV testing 2011 and beyond: can we make a difference? |
| Q34861515 | HIV testing among clients in high HIV prevalence venues: disparities between older and younger adults |
| Q34889163 | HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways |
| Q40253399 | HIV/AIDS-related deaths in China, 2000-2012. |
| Q42281560 | HIV: so near and yet so far. |
| Q35946584 | HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV. |
| Q52669144 | High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites. |
| Q43643786 | Home delivery of medication - the role of a patient information leaflet on maximising service uptake |
| Q44687077 | Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia |
| Q55342018 | Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function. |
| Q28354164 | Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam |
| Q33816061 | Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients |
| Q34405742 | Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. |
| Q92915228 | Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling |
| Q91650265 | Increasing the Offer, Shifting the Offer: Patients' Perspectives on Routinely Offering HIV Counseling and POC Testing in the Health Services Program of an Urban Community Health Centre |
| Q41534211 | Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort |
| Q56774036 | Late HIV diagnosis in Europe: a call for increased testing and awareness among general practitioners |
| Q34554118 | Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort study |
| Q36127917 | Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care |
| Q45781456 | Late presentation of HIV infection in the country of Georgia: 2012-2015. |
| Q34667707 | Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies |
| Q30756408 | Life expectancy after HIV diagnosis based on data from the counseling center for behavioral diseases |
| Q64903981 | Life expectancy and disparities in survival among HIV-infected people receiving antiretroviral therapy: an observational cohort study in Kathmandu, Nepal. |
| Q95360885 | Life expectancy and years of life lost in HIV patients under the care of BandarAbbas Behavioral Disorders Counseling Center |
| Q55214562 | Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study. |
| Q35693918 | Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada |
| Q38405857 | Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis |
| Q39590922 | Life expectancy trends in adults on antiretroviral treatment in South Africa |
| Q57002847 | Long term effect of primary health care training on HIV testing: A quasi-experimental evaluation of the Sexual Health in Practice (SHIP) intervention |
| Q31106702 | Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy |
| Q89468682 | Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function |
| Q26995231 | Low levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelines |
| Q41670514 | Meeting the complex needs of individuals living with HIV: a case study approach |
| Q60640918 | Mindfulness-Based Cognitive Therapy application for People Living with Chronic Disease: the case of HIV |
| Q37262127 | Misdiagnosis of Treatable Stroke Mimic: The Case for HIV Screening in Practice Guidelines |
| Q38130195 | Missed opportunities for HIV diagnosis: a three-year audit in the West of Scotland |
| Q89627154 | Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan |
| Q42282082 | Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study |
| Q34282914 | Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome |
| Q33668524 | Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care |
| Q36912621 | Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study |
| Q44870150 | Oregon patients with HIV infection who experience delayed diagnosis |
| Q37591592 | Personalized life expectancy and treatment benefit index of antiretroviral therapy |
| Q33859713 | Phenotype and Treatment of Breast Cancer in HIV-Positive and -Negative Women in Cape Town, South Africa |
| Q35454365 | Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study |
| Q36389902 | Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care |
| Q30151864 | Preparedness for use of the rapid result HIV self-test by gay men and other men who have sex with men (MSM): a mixed methods exploratory study among MSM and those involved in HIV prevention and care |
| Q90728231 | Prescription of antimicrobials in primary health care as a marker to identify people living with undiagnosed HIV infection, Denmark, 1998 to 2016 |
| Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
| Q37372650 | Primary prophylaxis of disseminated histoplasmosis in HIV patients in French Guiana: arguments for cost effectiveness |
| Q39658320 | Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls. |
| Q35526724 | Projected Lifetime Healthcare Costs Associated with HIV Infection |
| Q92447196 | Qualitative evaluation of a pilot educational intervention to increase primary care HIV-testing |
| Q36908984 | Recent HIV Testing Prevalence, Determinants, and Disparities Among U.S. Older Adult Respondents to the Behavioral Risk Factor Surveillance System |
| Q30235024 | Recent Insights into the HIV/AIDS Pandemic |
| Q37552585 | Republished: unlocking the potential: longitudinal audit finds multifaceted education for general practice increases HIV testing and diagnosis |
| Q35661739 | Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy |
| Q95650676 | Routine HIV testing in acute care hospitals: Changing practice to curb a local HIV epidemic in Vancouver, BC |
| Q40321349 | Significant benefit of a targeted HIV testing module on medical students' knowledge and confidence |
| Q35766649 | Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention |
| Q34823231 | Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America |
| Q37391610 | Socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study |
| Q102389112 | Spin-enhanced nanodiamond biosensing for ultrasensitive diagnostics |
| Q28555090 | Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics |
| Q38401028 | Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies |
| Q36754382 | TOGETHER Project to Increase Understanding of the HIV Epidemic Among Sub-Saharan African Migrants: Protocol of Community-Based Participatory Mixed-Method Studies. |
| Q51213908 | Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer. |
| Q35021706 | The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics |
| Q51758448 | The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics. |
| Q58797971 | The Aging Skeleton: Differences Between HIV-Infected Patients and the Uninfected Aging Population |
| Q37528500 | The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis |
| Q36516798 | The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients. |
| Q90043329 | The Effectiveness of Social Marketing Interventions to Improve HIV Testing Among Gay, Bisexual and Other Men Who Have Sex with Men: A Systematic Review |
| Q36559353 | The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections |
| Q34691650 | The cascade of care in the Eastern European country of Georgia |
| Q45347549 | The human immunodeficiency virus and ageing. |
| Q36137725 | The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada |
| Q40087072 | Transplantation of the Patient with Human Immunodeficiency Virus |
| Q88189442 | Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014 |
| Q37659815 | Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study |
| Q34579208 | Trends in HIV infection in the First Affiliated Hospital of Harbin, China |
| Q38851681 | Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population |
| Q39377107 | Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women |
| Q36764149 | Unlocking the potential: longitudinal audit finds multifaceted education for general practice increases HIV testing and diagnosis |
| Q93082285 | Use of a Retrospective Methodology to Examine the Process of Care Surrounding Serious Medical Events in HIV-Positive Patients: A Feasibility Study |
| Q36275141 | Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations |
| Q41547769 | Weight loss and chronic diarrhea in a 54-year-old man with HIV infection |